Ponatigen 45 Mg (Ponatinib)

Description

About Ponatigen 45 Mg

Each tablet of Ponatigen 45mg contains Ponatinib Hydrochloride INN equivalent to Ponatinib 45mg. Ponatinib is a kinase inhibitor. Ponatigen 45mg is manufactured by General Pharmaceuticals LTD. Each box of Ponatigen 45mg contains 30 tablets.

Dosage

Recommended dosage of Ponatigen 45 mg is one tablet orally once daily, with or without food, until disease progression or unacceptable toxicity. It should be taken at the same time each day. Whole capsule should be swallowed with water and the capsule should not be chewed or crushed. Or, as directed by the registered physician.

Side Effects

• Headache
• Dizziness
• Constipation
• Loss of appetite

Storage

Ponatigen 45mg should be stored below 30°C in a dry and clean place, away from sunlight and out of the reach of children.